Education
About Us
Working with TipRanks
Follow Us
Suven Life Sciences Limited (IN:SUVEN)
:SUVEN
Total Valuation
Suven Life Sciences Limited has a market cap or net worth of ₹49.49B. The enterprise value is ₹7.30B.
Market Cap₹49.49B
Enterprise Value₹7.30B
Share Statistics
Suven Life Sciences Limited has 218,073,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding218,073,720
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Suven Life Sciences Limited’s return on equity (ROE) is -1.46 and return on invested capital (ROIC) is -153.63%.
Return on Equity (ROE)-1.46
Return on Assets (ROA)-1.19
Return on Invested Capital (ROIC)-153.63%
Return on Capital Employed (ROCE)-1.54
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.05
Inventory Turnover144.38
Valuation Ratios
The current PE Ratio of Suven Life Sciences Limited is 0.00. Suven Life Sciences Limited’s PEG ratio is 2.17.
PE Ratio0.00
PS Ratio0.00
PB Ratio2.04
Price to Fair Value0.00
Price to FCF-7.22
Price to Operating Cash Flow-7.42
PEG Ratio2.17
Income Statement
In the last 12 months, Suven Life Sciences Limited had revenue of 66.56M and earned -1.61B in profits. Earnings per share was -7.37.
Revenue66.56M
Gross Profit-276.33M
Operating Income-1.72B
Pretax Income-1.61B
Net Income-1.61B
EBITDA-1.55B
Earnings Per Share (EPS)-7.37
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Suven Life Sciences Limited pays an annual dividend of ₹1.382, resulting in a dividend yield of ―
Dividend Per Share₹1.382
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.68
52-Week Price Change131.84%
50-Day Moving Average184.80
200-Day Moving Average144.18
Relative Strength Index (RSI)53.36
Average Volume (3m)150.29K
Important Dates
Suven Life Sciences Limited upcoming earnings date is Aug 11, 2025, TBA Not Confirmed.
Last Earnings DateMay 13, 2025
Next Earnings DateAug 11, 2025
Ex-Dividend DateFeb 14, 2019
Financial Position
Suven Life Sciences Limited as a current ratio of 3.21, with Debt / Equity ratio of 0.43%
Current Ratio3.21
Quick Ratio3.20
Debt to Market Cap0.00
Net Debt to EBITDA0.24
Interest Coverage Ratio-3.68K
Taxes
In the past 12 months, Suven Life Sciences Limited has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Suven Life Sciences Limited EV to EBITDA ratio is 0.24, with an EV/FCF ratio of 0.20.
EV to Sales-5.67
EV to EBITDA0.24
EV to Free Cash Flow0.20
EV to Operating Cash Flow0.25
Balance Sheet
Suven Life Sciences Limited has ₹1.66B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹1.66B billion.
Cash & Marketable Securities₹1.66B
Total Debt₹0.00
Net Cash-₹1.66B
Net Cash Per Share-₹7.63
Tangible Book Value Per Share₹0.00
Margins
Gross margin is 95.82%, with operating margin of -2578.13%, and net profit margin of -2415.11%.
Gross Margin95.82%
Operating Margin-2578.13%
Pretax Margin-2415.11%
Net Profit Margin-2415.11%
EBITDA Margin-2326.94%
EBIT Margin-2414.41%
Analyst Forecast
The average price target for Suven Life Sciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―